Evidence map›Paper›PMID 28133586›Full record

ReviewEnvironmental sciences Europe2017

Possible health impacts of Bt toxins and residues from spraying with complementary herbicides in genetically engineered soybeans and risk assessment as performed by the European Food Safety Authority EFSA.

Christoph Then, Andreas Bauer-Panskus

Erratum issuedOpen access · goldAbstract readReview
In one paragraph

Review in Environmental sciences Europe, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Recombinant antibodies and their use for food immunoanalysis.Analytical and bioanalytical chemistry · 2022
    Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Christoph ThenTestbiotech, Institute for Independent Impact Assessment in Biotechnology, Frohschammerstr. 14, 80807 Munich, Germany.
Andreas Bauer-PanskusTestbiotech, Institute for Independent Impact Assessment in Biotechnology, Frohschammerstr. 14, 80807 Munich, Germany.
Impact Assessment · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMON89788 was the first genetically engineered soybean worldwide to express a Bt toxin. Under the brand name

resultsWe have compared the opinion published by EFSA [1] with findings from other publications in the scientific literature. It is evident that there are several issues that EFSA did not consider in detail and which will need further assessment: (1) There are potential combinatorial effects between plant components and other impact factors that might enhance toxicity. (2) It is known that Bt toxins have immunogenic properties; since soybeans naturally contain many allergens, these immunogenic properties raise specific questions. (3) Fully evaluated and reliable protocols for measuring the Bt concentration in the plants are needed, in addition to a comprehensive set of data on gene expression under varying environmental conditions. (4) Specific attention should be paid to the herbicide residues and their interaction with Bt toxins.

conclusionsThe case of the

Indexed as

Bt toxinsGenetically engineered plantsHealth effectsHerbicide residuesRisk assessment

Identifiers

PMID28133586
PMCPMC5236067
OpenAlexW2574796360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.